Amplify ETF Trust Amplify Treatments, Testing and Advancements ETF (ARCA: GERM)
Ticker | Name | Share % | |
---|---|---|---|
ALNY | Alnylam Pharmaceuticals Inc Common Stock Usd 0.01 | 10.34% | |
LH | Laboratory Corporation Of America Holdings | 6.49% | |
DGX | Quest Diagnostics Inc | 6.10% | |
FF | Biontech Se | 4.91% | |
MRNA | Moderna therapeutics | 4.76% | |
PCVX | Vaxcyte Inc | 4.49% | |
IBRX | Immunitybio Inc. | 4.35% | |
BIO | Bio-Rad Laboratories-A Common Stock | 3.86% | |
SH | Zai Lab Ltd-adr | 3.85% | |
IMCR | Immunocore Holdings Ltd(180 Day Lock Up) | 3.61% |
The GERM ETF is currently trading at $20.94, which represents a 8.39% change. Over the past 52 weeks, the ETF has traded as high as $21.41 and as low as $15.67.
The expense ratio of GERM is 0.68%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for GERM is 9.72M. This represents the total market value of the assets managed by the ETF.
GERM follows a Mid Cap Growth investment style.
The top holdings of GERM include: ALNY (10.34%), LH (6.49%), DGX (6.10%), FF (4.91%), MRNA (4.76%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for GERM is currently not available.